C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/128.2, 195/1
C12N 15/81 (2006.01) C07K 14/62 (2006.01) C12N 15/17 (2006.01) C12P 21/06 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1337976
Insulin precursors characterized by the amino acid sequence B(1-29)-X1-X2-Y2-Y1-A(1-21) wherein B(1-29) are the 29 first amino acid residues of the B chain of human insulin starting from the N-terminus, A(1-21) are the 21 amino acid residues of the A chain of human insulin, X1 represents a peptide bond or one or more arbitrary amino acid residues, X2 represents Glu or Asp, and Y1 and Y2 each represents Lys or Arg, the positions A6 and A11, A7 and B7 and A20 and B19, respectively, are connected through sulphur bridges, and, if desired, one or more of the amino acid residues of the chains B(1-29) and A(1-21) are substituted by another amino acid residue, are provided. The insulin precursors are prepared by culturing a yeast strain transformed with a replicable expression vehicle comprising a DNA sequence encoding an insulin precursor of the above formula in a suitable medium and isolating the insulin precursor thus formed from the culture medium. The insulin precursors can be converted into human insulin or insulin analogues by enzymatic treatment in a manner known per se.
603208
Clausen Ib Groth
Jensen Ejner Bech
Jonassen Ib
Svendsen Allan
Gowling Lafleur Henderson Llp
Novo Nordisk A/s
LandOfFree
Insulin precursors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin precursors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin precursors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1231010